Oncology and Hematology

Fausto Loberiza Jr., M.D., M.S.

Professor, Internal Medicine
Division of Hematology & Oncology            

Academic office:
UNMC Oncology/Hematology Division
987680 Nebraska Medical Center
Omaha, NE 681980-7680
Ph. 402-559-5520
Fax 402-559-6520

University of Santo Tomas, Manila, Phils, MD(1991), Resident(1995)
University of Iowa, Iowa City, IA MS(1998),
Post-Doc Fellow(1998)

Health Services Research

Biographical Sketch:
Dr. Fausto Loberiza is a Professor in the Division of Hematology and Oncology in the Department of Internal Medicine at UNMC. Dr. Loberiza joined UNMC in January 2005, after serving as Assistant Professor and Assistant Scientific Director of the Center for International Blood and Marrow Transplant Registry (CIBMTR), the largest repository of longitudinal outcomes data on stem cell transplant patients throughout the world. His research interests include health services research in oncology and stem cell transplantation. His studies deal with understanding the complex interaction among social, psychological, cultural and spiritual factors and how these contribute to variations in clinical outcomes. Dr. Loberiza reviews for various journal in Oncology, Hematology, Transplantation and Psychiatry.

Selected Publications:

Loberiza FR Jr., Lee SJ, Freytes CO, et al. Methodological and logistical consideration to study design and data collection in racial/ethnic minority populations evaluating outcome disparity in hematopoietic cell transplantation. Biol Blood Marrow Transplant. In press.

Lee SJ, Astigarraga CC, Eapen M, Artz AS, Davies SM, Champlin R, Jagasia M, Kernan NA, Loberiza FR, Bevans M, Soiffer RJ, Joffe S. Variation in supportive care practices in hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2008 Nov;14(11):1231-8.

Ganti AK, Loberiza FR Jr, Kessinger A. Effect of family history on lung cancer outcomes. Lung Cancer 2008 Jun 21

Lee SJ, Joffe S, Artz A, Champlin RE, Davies S, Jagasia M, Kernan NA, Loberiza FR, Soiffer RJ, Eapen M. Individual Physician Practice Variation in Hematopoietic Cell Transplantation. J Clin Oncol. 2008 May 1;26(13):2162-70.

Rao K, Darrington DL, Schumacher JJ, Devetten MP, Vose JM, Loberiza FR. Disparity in survival outcome after hematopoietic stem cell transplantation for hematological malignancies according to area of primary residence. Biol Blood Marrow Transplant. 2007 Dec;13(12):1508-14

Ganti AK, Lee SJ, Vose JM, Devetten MP, Bociek RG, Armitage JO, Bierman PJ, Maness LJ, Reed EC, Loberiza FR. Outcomes following hematopoietic stem cell transplantation for hematologic malignancies in patients with or without advanced care planning. J Clin Oncol. 2007 Dec 10;25(35):5643-8.

Schwake C, Eapen M, Lee SJ, Freytes CO, Giralt SA, Navarro WH, Rizzo JD, Van Besien K, Loberiza FR. Differences in Characteristics of United States Hematopoietic Stem Cell Transplantation Centers by Proportion of Ethnic Minorities. Biol Blood Marrow Transplant. 2005 Dec;11(12):988-998.

Baker KS, Loberiza FR, Yu Hongmei, et al. Outcome of Ethnic Minorities with Acute or Chronic Leukemia treated with Hematopoietic Stem Cell Transplantation in the United States. J Clin Onc, Oct 1 2005: 7032–7042.

Loberiza FR, Zhang MJ, Lee SJ, Klein JP, LeMaistre CF, Serna DS, Eapen M, Horowitz MM, Rizzo JD. Association of Transplant Center and Physician Factors on Mortality after Hematopoietic Stem Cell Transplantation in the United States. Blood. 2005 April; 105(7) 2979-2987.

Serna D, Zhang MJ, Baker KS, Eapen M, Horowitz MM, Klein JP, Lee SJ, Rizzo JD, Loberiza FR. Trends in Survival Rates after Allogeneic Hematopoietic Stem Cell Transplantation For acute and Chronic leukemia by Race in The United States and Canada. J Clin Onc, 2003 Oct 15:21(20), 3754-3760.

Loberiza FR, Rizzo D, Bredeson C, Antin JH, Horowitz M, Weeks J, Lee SJ. Association of depressive symptoms and early deaths among patients following stem cell transplantation for hematologic disorders. J Clin Onc, 2002 April 15; 20 (8).